In another study, the combination of gold nanocar and LITT with anti-PD-L1 antibody reduced tumor growth, improved survival, and maintained a durable immune memory (rejection tumor rechallenge) in the CT-2A glioma murine model compared to those in the control group and monotherapy groups (120). Here, CD274 is linked to neoplasm.